SO
ENZ

STRS Ohio’s Enzo Biochem, Inc. ENZ Stock Holding History

STRS Ohio’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-185,000
Closed -$636K – 2456
2021
Q1 		$636K Sell
185,000
-68,000
-27% -$211K ﹤0.01% 1466
2020
Q4 		$637K Buy
253,000
+36,000
+17% +$78.4K ﹤0.01% 1348
2020
Q3 		$457K Buy
217,000
+8,000
+4% +$19K ﹤0.01% 1385
2020
Q2 		$468K Buy
209,000
+48,100
+30% +$124K ﹤0.01% 1352
2020
Q1 		$407K Hold
160,900
– – ﹤0.01% 1287
2019
Q4 		$423K Hold
160,900
– – ﹤0.01% 1501
2019
Q3 		$579K Buy
160,900
+10,200
+7% +$36.1K ﹤0.01% 1158
2019
Q2 		$507K Sell
150,700
-54,700
-27% -$193K ﹤0.01% 1299
2019
Q1 		$560K Buy
205,400
+19,300
+10% +$63.2K ﹤0.01% 1209
2018
Q4 		$517K Buy
186,100
+16,800
+10% +$55K ﹤0.01% 1229
2018
Q3 		$697K Buy
169,300
+35,700
+27% +$162K ﹤0.01% 1166
2018
Q2 		$693K Buy
133,600
+28,500
+27% +$174K ﹤0.01% 1200
2018
Q1 		$575K Buy
105,100
+25,100
+31% +$177K ﹤0.01% 1258
2017
Q4 		$652K Buy
80,000
+13,000
+19% +$124K ﹤0.01% 1195
2017
Q3 		$701K Buy
67,000
+4,500
+7% +$49.9K ﹤0.01% 1167
2017
Q2 		$690K Sell
62,500
-14,800
-19% -$138K ﹤0.01% 1113
2017
Q1 		$647K Sell
77,300
-19,700
-20% -$139K ﹤0.01% 1193
2016
Q4 		$673K Sell
97,000
-21,431
-18% -$137K ﹤0.01% 1165
2016
Q3 		$602K Buy
118,431
+9,031
+8% +$53.9K ﹤0.01% 1207
2016
Q2 		$653K Buy
+109,400
New +$607K ﹤0.01% 1103
2015
Q2 		– Sell
-169,847
Closed -$501K – 1951
2015
Q1 		$501K Buy
169,847
+16,447
+11% +$53.8K ﹤0.01% 1205
2014
Q4 		$681K Buy
153,400
+33,200
+28% +$158K ﹤0.01% 1065
2014
Q3 		$619K Sell
120,200
-4,700
-4% -$25.1K ﹤0.01% 1077
2014
Q2 		$656K Buy
+124,900
New +$540K ﹤0.01% 1101

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio's ENZ Position: Q2 2021 in Review

STRS Ohio sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 185,000 shares — an estimated $636K sold.

STRS Ohio first reported a position in ENZ in Q2 2014 and held it in 24 quarters. The position peaked at $701K in Q3 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

  • STRS Ohio reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
  • STRS Ohio sold 185,000 Enzo Biochem, Inc. shares in Q2 2021, an estimated $636K.
  • STRS Ohio first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 24 quarters.
  • STRS Ohio's Enzo Biochem, Inc. position peaked at $701K in Q3 2017.
  • 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on STRS Ohio's 13F filing for Q2 2021, filed 26 Jul 2021.